Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean D Sullivan

Showing results (211-220 of 325) with videos related to

Pageof 33
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2026
Potential Impact of the Medicare Prescription Payment Plan for Medicare Part D Beneficiaries With a Cancer DiagnosisAryana Sepassi, Scott D Ramsey, A Mark Fendrick, et al.
Journal of Managed Care & Specialty Pharmacy|May 5, 2025
The financial value of improving patient access to COVID-19 antiviral therapy in Medicare Part D: A simulation studyAndrew S Aguilar, Tyler Engel, Wesley Furnback, et al.
Pharmacoeconomics|February 21, 2004
Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis CSean D Sullivan, Antonio Craxi, Alfredo Alberti, et al.
International Journal of Technology Assessment in Health Care|July 8, 2008
Key principles for the improved conduct of health technology assessments for resource allocation decisionsMichael F Drummond, J Sanford Schwartz, Bengt Jönsson, et al.
European Journal of Gastroenterology & Hepatology|July 13, 2007
Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United KingdomDavid L Veenstra, Sean D Sullivan, Geoffry M Dusheiko, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 15, 2005
Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supplyBrian Custer, Eric S Johnson, Sean D Sullivan, et al.
JAMA|February 14, 2008
Expenditures and health status among adults with back and neck problemsBrook I Martin, Richard A Deyo, Sohail K Mirza, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force reportScott D Ramsey, Richard J Willke, Henry Glick, et al.
The American Journal of Managed Care|September 30, 2010
Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancerScott D Ramsey, Jeannine S McCune, David K Blough, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2007
Asthma control, severity, and quality of life: quantifying the effect of uncontrolled diseaseHubert Chen, Michael K Gould, Paul D Blanc, et al.
Pageof 33

Showing results (211-220 of 325) with videos related to

Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2026
Potential Impact of the Medicare Prescription Payment Plan for Medicare Part D Beneficiaries With a Cancer DiagnosisAryana Sepassi, Scott D Ramsey, A Mark Fendrick, et al.
Journal of Managed Care & Specialty Pharmacy|May 5, 2025
The financial value of improving patient access to COVID-19 antiviral therapy in Medicare Part D: A simulation studyAndrew S Aguilar, Tyler Engel, Wesley Furnback, et al.
Pharmacoeconomics|February 21, 2004
Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis CSean D Sullivan, Antonio Craxi, Alfredo Alberti, et al.
International Journal of Technology Assessment in Health Care|July 8, 2008
Key principles for the improved conduct of health technology assessments for resource allocation decisionsMichael F Drummond, J Sanford Schwartz, Bengt Jönsson, et al.
European Journal of Gastroenterology & Hepatology|July 13, 2007
Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United KingdomDavid L Veenstra, Sean D Sullivan, Geoffry M Dusheiko, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 15, 2005
Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supplyBrian Custer, Eric S Johnson, Sean D Sullivan, et al.
JAMA|February 14, 2008
Expenditures and health status among adults with back and neck problemsBrook I Martin, Richard A Deyo, Sohail K Mirza, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force reportScott D Ramsey, Richard J Willke, Henry Glick, et al.
The American Journal of Managed Care|September 30, 2010
Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancerScott D Ramsey, Jeannine S McCune, David K Blough, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2007
Asthma control, severity, and quality of life: quantifying the effect of uncontrolled diseaseHubert Chen, Michael K Gould, Paul D Blanc, et al.
Pageof 33